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Summary
We present the case of a child with idiopathic interstitial lung disease unresponsive to ste-
roids, diagnosed by biopsy. Recurrent respiratory infections contraindicated more aggressi-
ve immunosuppressive treatment. Physical growth was markedly unsatisfactory. Because of
the progressive deterioration of lung function, and of the continuous need for oxygen ad-
ministration, a heart/double-lung transplantation was performed. At present, 4 years after
the procedure, the patient appears clinically stable, with normal spirometry parameters.
Riassunto
Descriviamo il caso di un bambino con polmonite interstiziale idiopatica diagnosticata
con la biopsia polmonare e non responsiva al trattamento cortisonico. L’aggiunta di altra
terapia immunosoppressiva era controindicata dalla elevata frequenza di infezioni respi-
ratorie ricorrenti. L’accrescimento staturo-ponderale era marcatamente compromesso. A
causa del progressivo peggioramento clinico respiratorio e della continua necessità di
ossigeno abbiamo effettuato un trapianto cuore-polmone. Attualmente, a distanza di 4 anni,
il paziente è in buone condizioni cliniche e la funzionalità respiratoria è nella norma.
Introduction
The term interstitial lung disease (ILD) encompasses a wide range of condi-
tions in which the clinical symptoms primarily include dyspnea or breathles-
sness on exertion and/or at rest, and cough. Main histological findings consist
of the infiltration of inflammatory cells, associated with fibrotic changes cha-
racterized by fibroblast proliferation and excessive collagen deposition 1.
ILD in children represents a real challenge for physicians because of difficul-
ties in making the diagnosis and because treatment is sometimes less than op-
timal 2. Indeed, although most pediatric ILD are caused by infectious agents
and are characterized by a quite good outcome the cases reported are similar
to adult idiopathic interstitial pneumonias, in whom the etiology is hard to
identify, the response to treatment sometimes poor, and worsening of lung
function may lead to respiratory failure 3.
We herein report the case of a child with ILD unresponsive to steroids in whom
lung transplantation was performed with good results.
Case report
A four year-old Caucasian boy, whose parents are first-degree cousins, was re-
ferred to our unit with a 1-year history of cyanosis and dyspnea on exertion.
The family history was negative for respiratory diseases. He was free of respi-
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ratory symptoms, and physical growth had been sati-
sfactory until age 3 years, when progressive shortness of
breath on exertion, cyanosis and fatigability began. His
parents had noted the development of clubbing of the
fingers six months earlier. In the year prior to admission
in our unit he had experienced a few episodes of upper
respiratory tract infections with fever and cough.
At presentation the examination revealed fine, crackling
rales audible over both lung fields. The patient had dry
cough. There was prominent clubbing and moderate to
severe labial and limb cyanosis. Room air resting blood
gases indicated an arterial oxygen tension (PaO2) of 48
mm Hg, a carbon dioxide tension (PaCO2) of 36 mm Hg,
a pH of 7,35, and an oxygen saturation (SaO2) of 70%.
Cardiac evaluation excluded heart failure. However, the
electrocardiogram showed right ventricular hyper-
trophy. B-mode and Doppler echocardiography showed
dilatation of the right heart cavities and pulmonary ar-
tery; a high speed tricuspid regurgitation was also evi-
dent. Estimated pulmonary systolic pressure was 50 mm
Hg while breathing 21% FiO2, and dropped to 25 mmHg
when breathing 100% oxygen.
The chest x-ray and the high resolution computed tomo-
graphy (HRCT) of the lung revealed bilateral interstitial
linear and reticular opacities with areas of ground glass
appearance mostly at the base (Fig. 1A, B). Immunode-
ficiency and malignancy were excluded. Exposure to
pets, metals or organic dusts, and atopy were excluded.
Diagnostic tests for gastroesophageal reflux and swal-
lowing disorders were negative. Cultures obtained by
nasal wash, and infectious titers were negative. Connec-
tive tissue diseases, including rheumatoid arthritis, sy-
stemic lupus erythematosus, polymyosite and scleroder-
ma were excluded. The sweat test was negative and the
patient had never received drugs associated with pulmo-
nary toxicity. Gallium-67 scintiscan showed diffuse,
mildly increased uptake in both lungs. Bronchoalveolar
lavage (BAL) count showed 350 x 103 cells x mm-3 with
30% macrophages, 1% lymphocytes, 38,5% neu-
trophils, 30% eosinophils. No pathogens were identi-
fied. The thoracoscopic lung biopsy demonstrated
uniform intense to moderate fibrosis. Uniform thicke-
ning of the alveolar wall due to expansion of the cellu-
lar matrix, with large numbers of proliferating fibrobla-
sts and dense deposits of collagen and elastin fibers we-
re evident. Cells infiltrating the alveolar septa were
mainly fibroblasts and monocytes. Hyperplasia of type
II pneumocytes covering the surface of most alveoli was
also present (Fig. 2A, B).
Continuous oxygen and oral prednisone (2 mg/kg/day)
therapy were started. After 6 months of treatment, the
Gallium-67 scan and the HRCT of the chest appeared
substantially unchanged. Room air blood gases analysis
revealed a PaO2 of 58 mmHg and a CO2 of 43 mmHg.
The results of the physical examination and cardiac eva-
luation were unchanged. Recurrent respiratory tract in-
fections requiring antibiotic treatment occurred, con-
traindicating treatment with immunosuppressive agents.
Exercise tolerance was minimal and physical growth
was markedly unsatisfactory. A heart/double-lung tran-
splantation was proposed and successfully performed.
At present, 4 years after the procedure the patient ap-
pears clinically stable. The spirometry is within normal
values; the patient has returned to a fully active life.
Discussion
We report on a patient with idiopathic ILD unresponsi-
ve to corticosteroid treatment in whom progressive pul-
monary deterioration, complicated by severe failure to
thrive and recurrent respiratory infections contraindica-
ting more aggressive immunosuppressive drugs, led to
the decision of lung transplantation.
Currently, pediatric ILD are being reported more fre-
quently than in the past 1. For most patients, respiratory
pathogens, mainly viruses, are the primary causative
agents and the episodes are self limited. However, a li-
mited number of cases may present with progressive si-
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Fig. 1. (A) Chest x-ray showing reticulonodular densities. (B)
HRCT scan showing diffuse interstitial thickening of the intra-in-
terlobular septa, diffuse reticulonodular densities, and a predo-
minance of ground glass opacities at the lung bases.
gns and symptoms and do not respond to oral steroids 3.
More aggressive immunosuppressive agents may be ad-
ministered, but conflicting results have been obtained in
both children and adults 2. A recent preliminary study of
adults treated with interferon gamma plus prednisolone
has demonstrated substantial improvement in the pa-
tients who had had no response to steroids alone 4. Lung
transplantation may thus represent an alternative and
successful option.
According to the Katzenstein classification, most idio-
pathic ILD are rarely seen in children, with the only ex-
ception of non specific pneumonitis (NSIP). NSIP is de-
fined as a chronic form of ILD lacking both the hetero-
geneity and the variegated pattern of usual pneumonitis
(UIP), as well as the extensive accumulation of pigmen-
ted alveolar macrophages that characterizes the desqua-
mative pneumonia (DIP) 5. The pathologic criteria of
NSIP include interstitial inflammation and/or fibrosis,
the proportion of which could vary over a spectrum ran-
ging from pure chronic inflammatory cell infiltration to
fibrosis without any interstitial component 5. The clini-
cal features mainly include a subacute onset, the relati-
ve lack of clubbing, a rather low mortality rate, good re-
sponse to steroids and frequent clinical recovery 6. Ne-
vertheless some cases may exhibit clinical and hystolo-
gical features resembling idiopathic interstitial fibrosis,
and these patients seem to be at greater risk of dying
than those with cellular, non fibrotic lesions.
Whether our patient would fit the Katzenstein model of
the histological and clinical course of ILD is still open to
question. Presenting symptoms, chest examination, lung
imaging findings showing interstitial reticulonodular pat-
tern prominent at the lung bases with ground-glass opa-
cities, and finally the poor response to steroids with pro-
gressive clinical deterioration make it difficult to distin-
guish this case from UIP. The lung biopsy indicated a fi-
brotic lung disease with type II cells hyperplasia and fi-
broblast proliferation, which is very uniform; this would
be very atypical for UIP, in which the distribution of the-
se changes is rather patchy. The histological pattern
looks more like what was described by Katzenstein as
NSIP type III, which is characterized by minimal in-
flammation but extensive fibrosis 5. BAL findings in this
case were also somewhat atypical, in that there was an
extremely high eosinophil count. While eosinophilia in
ILD indicates poor prognosis 7, it usually does not reach
this level, but this still remains a possibility.
A recent multicentre survey on pediatric ILD pointed
out the difficulties in applying the classification of
adults ILD to children 8. In this study, in 61% of the ca-
ses in whom the pathologists were unable to classify the
histological pattern, the term of «non classified fibrosis»
was used; in the remaining 35% a clear histological de-
finition of the disease as DIP or UIP or NSIP or LIP was
made.
Registry data from the International Society for Heart
and Lung Transplantation demonstrates that ILD is the
second most common indication for lung transplantation
9
. The successful outcome achieved in our patients after
the lung transplant confirms that with increasing techni-
cal refinements and experience lung and/or heart-lung
transplantation can be hopefully successful even in pe-
diatric patients with ILD.
In conclusions, our knowledge about ILD in children
has been limited in the past by the perception that it is
uncommon at this age. The availability and applicability
of diagnostic procedures in children has resulted in an
increased number of pediatric diagnoses 8. Finally, we
confirm that even in children unresponsive to oral glu-
cocorticoids, progressive ILD represents an indication
for lung transplantation.
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Fig. 2. (A) Low magnification micrograph of the thoracoscopic
lung biopsy specimen showing uniform thickening of the alveo-
lar wall with large numbers of proliferating fibroblasts and den-
se deposits of collagen and elastin fibers. Alveolar contents
show a large number of macrophages. Hematoxylin and eosin;
original magnification: x 125. (B) High magnification micrograph
of the same specimen showing fibrosis of alveolar septa with lar-
ge numbers of proliferating fibroblasts. Note the type 2 alveolar
cells hyperplasia and the macrophages into the alveolar space.
Hematoxylin and eosin; original magnification: x 250.
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